ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

KALA KALA BIO Inc

6,30
0,12 (1,94%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
KALA BIO Inc KALA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,12 1,94% 6,30 06:00:14
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
6,32 6,24 6,5399 6,30 6,18
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.3.202413:00GLOBEKALA BIO Reports Fourth Quarter and Full Year 2023 Financial..
04.3.202413:30EDGAR2Form 8-K - Current report
26.2.202414:00GLOBEKALA BIO to Present at TD Cowen 44th Annual Healthcare..
14.2.202419:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06.2.202414:00GLOBEKALA BIO to Present at Oppenheimer 34th Annual Healthcare..
19.1.202422:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05.1.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202314:22EDGAR2Form 8-K - Current report
13.11.202314:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202314:05EDGAR2Form 8-K - Current report
13.11.202314:00GLOBEKALA BIO Reports Third Quarter 2023 Financial Results and..
18.10.202322:04EDGAR2Form SC 13D/A - General statement of acquisition of..
20.9.202322:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05.9.202314:00GLOBEKALA BIO to Present at H.C. Wainwright 25th Annual Global..
04.8.202314:00GLOBEKALA BIO Reports Second Quarter 2023 Financial Results and..
02.8.202322:01EDGAR2Form 8-K - Current report
02.8.202322:01GLOBEKALA BIO to Participate in Upcoming Investor Conferences in..
02.8.202314:00GLOBEKala Pharmaceuticals Announces Name Change to KALA BIO
19.7.202322:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..
23.6.202322:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..
02.6.202314:00GLOBEKala Pharmaceuticals to Present at the Jefferies Healthcare..
09.5.202314:00GLOBEKala Pharmaceuticals Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock